Holen Sie sich die Stockscreener-App
1.79
1.13%
0.02
Handel nachbörslich:
1.82
0.03
+1.68%
Schlusskurs vom Vortag:
$1.77
Offen:
$1.78
24-Stunden-Volumen:
255.93K
Relative Volume:
0.46
Marktkapitalisierung:
$67.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.19%
1M Leistung:
+0.00%
6M Leistung:
-23.18%
1J Leistung:
-42.07%
1-Tages-Spanne:
$1.738
$1.82
1-Wochen-Bereich:
$1.65
$1.86
52-Wochen-Spanne:
$1.23
$4.00
Metagenomi Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Vergleichen Sie MGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.79 | 66.46M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
Gainers Report: Is Metagenomi Inc stock dividend yield sustainableFed Meeting & Weekly Top Performers Watchlists - moha.gov.vn
Is Metagenomi Inc. stock dividend yield sustainableWide Width Options & HOKA model picks for your routine - ulpravda.ru
Operating cash flow per share of Metagenomi, Inc. – NASDAQ:MGX - TradingView — Track All Markets
Patterns Watch: Is Metagenomi Inc. stock undervalued vs historical averages2025 Historical Comparison & Consistent Profit Trading Strategies - ulpravda.ru
Is Metagenomi Inc. stock positioned well for digital economy2025 Stock Rankings & AI Forecasted Entry and Exit Points - ulpravda.ru
Is Metagenomi Inc. stock a defensive play in 2025Earnings Miss & Weekly High Momentum Picks - ulpravda.ru
Will Metagenomi Inc. stock attract ESG investors2025 Short Interest & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
How interest rate cuts could boost Metagenomi Inc. stock2025 Trading Volume Trends & High Accuracy Investment Entry Signals - ulpravda.ru
Market Overview: Is Metagenomi Inc. stock supported by innovation pipelineWeekly Profit Summary & Expert-Curated Trade Recommendations - ulpravda.ru
Is Metagenomi Inc. stock in correction or buying zoneWeekly Investment Report & Capital Efficiency Focused Ideas - ulpravda.ru
Oklahoma City NewsThe OklahomanMetagenomi, Inc.Common Stock (Nasdaq:MGX) Detailed Stock Data - FinancialContent
Is Metagenomi Inc. stock supported by innovation pipelineAnalyst Upgrade & Entry Point Confirmation Alerts - ulpravda.ru
Why Metagenomi Inc. stock attracts global investorsJuly 2025 Summary & Long-Term Capital Growth Ideas - ulpravda.ru
Is Metagenomi Inc. stock attractive after correctionHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - ulpravda.ru
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World
Exit Recap: Is Metagenomi Inc stock supported by innovation pipeline2025 Trading Volume Trends & Fast Moving Stock Trade Plans - moha.gov.vn
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com South Africa
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Metagenomi Earnings Notes - Trefis
CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
Why analysts upgrade Metagenomi Inc. stock2025 Price Targets & High Win Rate Trade Alerts - Улправда
Is Metagenomi Inc. stock recession proofJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India
Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia
Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com
Metagenomi general counsel Wein sells $352 in stock - Investing.com
Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser
Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat
Metagenomi’s general counsel Wein sells $360 in stock - Investing.com India
Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria
Finanzdaten der Metagenomi Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Metagenomi Inc-Aktie (MGX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wein Matthew | See Remarks |
Dec 05 '25 |
Sale |
1.77 |
199 |
353 |
115,031 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '25 |
Sale |
1.77 |
1,576 |
2,793 |
188,956 |
| Irish Jian | Chief Executive Officer |
Dec 05 '25 |
Sale |
1.77 |
1,602 |
2,839 |
563,839 |
| Thomas Brian C. | Director |
Sep 05 '25 |
Sale |
1.81 |
2,701 |
4,889 |
2,514,790 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '25 |
Sale |
1.81 |
1,576 |
2,853 |
70,532 |
| Irish Jian | Chief Executive Officer |
Sep 05 '25 |
Sale |
1.81 |
1,602 |
2,900 |
316,941 |
| Wein Matthew | See Remarks |
Sep 05 '25 |
Sale |
1.81 |
199 |
360 |
19,230 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):